Massachusetts Ballot Measure 8 (2026): Marijuana Legalization Repeal Initiative

Executive summary

Massachusetts Ballot Measure 8 is a November 3, 2026 citizen initiative that would roll back the state's adult-use cannabis law, and a campaign called No on 8: Stop the Repeal is spending to defeat it. It would be the first time voters in a state with a mature legal market were asked to reverse legalization at the ballot box.

On September 29-30, 2026, the No on 8 campaign released two new ads, according to Marijuana Moment. One features Alan Balsam, a former commissioner of public health. The campaign's argument is that a "no" vote keeps licensed recreational dispensaries open.

The stakes are large. Massachusetts voters approved adult-use legalization in 2016 by a margin of roughly 54% to 46%, and the market that followed has recorded billions of dollars in cumulative sales. It supports more than 400 licensed retail storefronts, thousands of jobs, and a municipal tax base that many cities and towns now rely on.

This page tracks the measure's text, the campaigns, the legal mechanics under Article 48 of the Massachusetts Constitution, and the market consequences. Ballot language and campaign finance details can change. The official Information for Voters guide from the Secretary of the Commonwealth is the controlling source for what the measure does. Where this page describes the measure's scope, it relies on press reporting and the campaign framing described above.

Why this matters

Measure 8 puts a roughly $1.5-billion-a-year retail market, a municipal revenue stream, and a national precedent on a single ballot line. Operators, patients, towns, investors, and other legal states are all watching.

Stakeholders and scale

• Consumers and patients. Adult-use customers buy at licensed stores in Massachusetts. Medical patients, who have had access since the 2012 medical law, share much of the same supply chain and many of the same storefronts.
• Licensees. Retailers, cultivators, product manufacturers, delivery operators, and testing labs hold licenses from the Cannabis Control Commission (CCC). Multi-state operators (MSOs) and single-state independents are both exposed.
• Municipalities. Under host community agreements, cities and towns collect local revenue. State law caps the local option tax at 3%, and agreements can also include impact fees.
• The state. Massachusetts collects a 10.75% cannabis excise tax plus the 6.25% sales tax on adult-use purchases, so a rollback affects the state budget as well.
• Other legal states. A result in either direction becomes evidence in debates in states such as California, New York, and Ohio.

The precedent problem

Ballot initiatives have legalized cannabis in nearly every state that took the initiative route. A rollback vote runs the other direction. If it fails, opponents of legalization lose their most visible test of whether voter sentiment has turned. If it passes, it becomes a template for repeal campaigns elsewhere.

Background and history

Massachusetts moved from a $100 civil fine in 2008 to a licensed adult-use market in 2018 through three ballot questions that each passed, and Measure 8 is the first effort to reverse that sequence. Understanding the earlier votes explains both the campaigns' arguments and the legal landscape.

2008: Question 2 decriminalizes possession

Voters approved Question 2 in November 2008 with about 65% support. It converted possession of one ounce or less from a criminal offense into a civil infraction carrying a $100 fine. It also set the template for how Massachusetts voters used the initiative process on cannabis, passing it by a wide margin over a vocal opposition from some prosecutors and public-health groups.

2012: Question 3 creates medical access

Question 3, approved in November 2012 with roughly 63% of the vote, legalized medical marijuana and created a registry of nonprofit dispensaries. Implementation was slow and contentious, with licensing delays and local zoning fights. The medical program established the supply chain, testing norms, and patient base that adult-use later built on.

2016: Question 4 legalizes adult use

Voters approved Question 4 on November 8, 2016, with about 53.7% in favor. The law took effect in December 2016 and allowed adults 21 and older to possess up to one ounce in public and ten ounces at home. It also allowed up to six plants per adult and twelve per household. It created the CCC as an independent regulator and set the tax structure, including the 3% local option.

The initiative became law as Chapter 334 of the Acts of 2016. The Legislature then amended it with Chapter 351 of the Acts of 2016, delaying the licensing timeline by six months. It later rewrote parts of the framework in Chapter 55 of the Acts of 2017, which raised the tax rates and shifted some regulatory authority. Those changes showed that Massachusetts lawmakers are willing to revise voter-approved cannabis law after the fact. That is relevant to how a Measure 8 passage could play out.

2018: Retail sales begin

The first adult-use stores opened on November 20, 2018, in Leicester and Northampton. Early growth was constrained by local bans and licensing bottlenecks, since municipalities that voted against Question 4 in 2016 could ban or limit stores by local vote. Supply shortages and long lines marked the first year.

2019-2022: Expansion and equity

The CCC licensed more storefronts, added delivery and social-consumption pathways, and ran Social Equity and Economic Empowerment programs. Disputes over host community agreements drew scrutiny, and the CCC and the Legislature moved to rein in what communities could demand of licensees. Neighboring states launched markets in this period: Rhode Island and Connecticut opened retail sales, which reduced Massachusetts' border-state advantage.

2023-2025: Price compression and a maturing market

Wholesale flower prices fell sharply as cultivation capacity grew. Operators reported margin pressure while retail locations multiplied. Annual sales plateaued in the neighborhood of $1.5-1.6 billion, according to CCC data tracked by industry press. In the 2024 election, voters rejected a psychedelics legalization question, which signaled limits on further liberalization even as the cannabis market held steady.

2025-2026: The repeal initiative qualifies

An initiative petition to roll back the adult-use law advanced through the Article 48 process, which includes review by the Attorney General, signature gathering, a legislative window, and a second round of signatures. It was assigned Question 8 for the November 3, 2026 ballot. In the closing weeks, the No on 8: Stop the Repeal campaign released advertising, including the spot with Balsam reported on September 30, 2026.

Key players

The fight pits a defense campaign built around public-health and economic messengers against a repeal coalition whose positions track long-standing prevention-oriented opposition to commercial cannabis.

No on 8: Stop the Repeal

This is the committee defending the current law. According to Marijuana Moment, its newest ads argue that a "no" vote keeps recreational dispensaries open. One spot features Alan Balsam, a former commissioner of public health, a choice that aims to counter the public-health framing repeal advocates typically use.

The repeal proponents

The measure's backers argue that commercial cannabis has produced harms, including youth exposure, impaired driving, and the effects of high-potency products. Nationally, groups such as Smart Approaches to Marijuana have argued that the commercial industry resembles tobacco and alcohol marketing. Readers should consult the Office of Campaign and Political Finance filings and the Secretary of the Commonwealth's guide for the precise list of petitioners and committees backing Question 8.

Cannabis Control Commission

The CCC regulates licensing, compliance, testing, and market data in Massachusetts. It does not take positions in ballot campaigns, but it would carry out any statutory changes and manage a wind-down if one were required. Its published sales data is the main factual source in the debate.

Secretary of the Commonwealth and Attorney General

Under Article 48, the Attorney General certifies that a petition meets constitutional requirements and writes the summary. The Secretary of the Commonwealth administers signature certification, the ballot, and the voter information guide mailed to households.

Industry and operators

Massachusetts-based independents, social equity licensees, and national MSOs such as Curaleaf, Ascend Wellness Holdings, Verano, and MariMed hold licenses in the state. Their trade associations and individual companies have strong incentives to fund or support the defense. Disclosed contributions appear in state campaign finance reports.

The Legislature and the Governor

Lawmakers had an opportunity to enact the proposal or a compromise before it went to voters, and they did not. If voters approve a measure, the Legislature retains power to amend it, as it did with Question 4 in 2016-2017.

Legal and regulatory framework

Question 8 is a statutory initiative under Article 48 of the Massachusetts Constitution, which means it needs a simple majority and at least 30% of all ballots cast, and it remains subject to later legislative amendment.

Article 48 mechanics

Massachusetts allows citizens to propose laws through an initiative petition. The process runs through these stages:

1. Sponsors file with the Attorney General, who certifies that the proposal is properly formed and writes the summary.
2. Sponsors collect signatures to place the proposal before the Legislature.
3. The Legislature has until early May of the election year to enact it.
4. If lawmakers do not act, sponsors collect additional signatures in the summer to place it on the November ballot.

To pass, a statutory initiative must win a majority of votes cast on the question, and the yes votes must equal at least 30% of total ballots cast in the election. Once passed, an initiative law takes effect on the date stated in the measure or by default roughly 30 days after the election.

The statutes at stake

Adult use is governed primarily by M.G.L. c. 94G (regulation of marijuana not medically prescribed) and c. 94I, with the CCC's regulations at 935 CMR 500. Medical use is governed by the 2012 law and corresponding CCC rules. The specific sections Question 8 would repeal or amend determine whether home possession, home cultivation, and medical access remain intact. Voters should read the Attorney General's summary and the Information for Voters guide for exact scope.

Federal overlay

Cannabis remains a Schedule I controlled substance under 21 U.S.C. § 812, enforced by the DEA. In December 2025, President Trump signed an executive order directing federal agencies to expedite rescheduling to Schedule III. Final rescheduling would not legalize state markets, but it would end 280E tax treatment for licensees, which changes the economics of the industry the measure targets. Separately, the federal appropriations law enacted in November 2025 redefined hemp in a way that restricts many intoxicating hemp-derived products